Board of Directors

Mr. Wit has been a member of the Board of Directors since November 1999 and CEO and President since June of 2002. Mr. Wit was interim CEO during June and July 2002. He was the President of Corporate Finance at Noesis Capital Corp, Boca Raton, Florida, a NASD member firm, from March 1995 until May 2002. Prior to 1994 Mr. Wit was the CEO for DMV, USA, the American subsidiary of Campina Melkunie, a Dutch multi-billion dollar food and pharmaceutical ingredients company. He also served as Vice President International Operations for Duphar, a pharmaceutical company in Holland. Mr. Wit graduated from Nyenrode, a business university in Holland.

Randall G. Smith

Mr. Smith (Chairman) has been an executive officer and member of the Board of Directors since 1997. He served as President and Chief Technology Officer from May 1997 until August 2000 and thereafter as Chairman and Chief Technology Officer. From December 1995 to May 1997, he was Director of Operations for Global Communications Group. Mr. Smith received a B.S. from Purdue University.

Guus van Kesteren

Mr. van Kesteren has been a member of our Board of Directors since November 1999. Since 1996 Mr. van Kesteren has been a consultant to Noesis Capital Corp., a NASD member firm. Prior thereto, he was employed from 1972 until 1996 by Johnson & Johnson in various capacities, holding the position of Vice President International from 1985 until 1996 with responsibility for the Australasian subsidiaries. Mr. van Kesteren graduated from Nyenrode, a business university in Holland.

Matthew D. Veatch

Mr. Veatch has been a member of our Board of Directors since February 2004. Since 1999 Mr. Veatch has been employed as an Executive Director for Quintiles Transnational, a global leader in contract product development and commercialization services. From 1997 to 1999 Mr. Veatch was employed as a Director for Affiliated Research Centers. Mr. Veatch graduated from the University of Colorado at Boulder and received his MBA from California State University, Dominguez Hills.

Dr. Jonathan Seltzer

Dr. Seltzer is President of Applied Clinical Intelligence, LLC. which offers highly efficient risk reduction solutions for clinical research such as the iCommittees™ Solution, expertise for Data Monitoring Committees (DSMBs) and EACs. Prior to his current role, Dr. Seltzer served as Vice President for Premier Research Worldwide as well as Deputy Director of the Office of Health Policy at Thomas Jefferson University. Currently he serves as President and Chair of the Board of Trustees of the Academy of Pharmaceutical Physicians and Investigators, and on their behalf, he serves on the Steering Committee of the Clinical Trial Transformation Initiative. Additionally, he is Director of Clinical Research at the Main Line Health Heart Center. Dr. Seltzer received board-certification in both cardiology and internal medicine. He holds a B.A. from Haverford College, an M.B.A. and M.A. from the University of Michigan, and an M.D. from the University of Pennsylvania. He received postgraduate medical training at the universities of Michigan, Maryland and Chicago. He is a Fellow of the American College of Cardiology.